5-150115832-T-C
Variant names:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_002609.4(PDGFRB):c.3252A>G(p.Pro1084Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.401 in 1,611,204 control chromosomes in the GnomAD database, including 134,319 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.37 ( 10631 hom., cov: 33)
Exomes 𝑓: 0.40 ( 123688 hom. )
Consequence
PDGFRB
NM_002609.4 synonymous
NM_002609.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -4.13
Genes affected
PDGFRB (HGNC:8804): (platelet derived growth factor receptor beta) The protein encoded by this gene is a cell surface tyrosine kinase receptor for members of the platelet-derived growth factor family. These growth factors are mitogens for cells of mesenchymal origin. The identity of the growth factor bound to a receptor monomer determines whether the functional receptor is a homodimer (PDGFB or PDGFD) or a heterodimer (PDGFA and PDGFB). This gene is essential for normal development of the cardiovascular system and aids in rearrangement of the actin cytoskeleton. This gene is flanked on chromosome 5 by the genes for granulocyte-macrophage colony-stimulating factor and macrophage-colony stimulating factor receptor; all three genes may be implicated in the 5-q syndrome. A translocation between chromosomes 5 and 12, that fuses this gene to that of the ETV6 gene, results in chronic myeloproliferative disorder with eosinophilia. [provided by RefSeq, Aug 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BP6
Variant 5-150115832-T-C is Benign according to our data. Variant chr5-150115832-T-C is described in ClinVar as [Benign]. Clinvar id is 258779.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-150115832-T-C is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=-4.13 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.429 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PDGFRB | NM_002609.4 | c.3252A>G | p.Pro1084Pro | synonymous_variant | Exon 23 of 23 | ENST00000261799.9 | NP_002600.1 | |
PDGFRB | NM_001355016.2 | c.3060A>G | p.Pro1020Pro | synonymous_variant | Exon 22 of 22 | NP_001341945.1 | ||
PDGFRB | NM_001355017.2 | c.2769A>G | p.Pro923Pro | synonymous_variant | Exon 23 of 23 | NP_001341946.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PDGFRB | ENST00000261799.9 | c.3252A>G | p.Pro1084Pro | synonymous_variant | Exon 23 of 23 | 1 | NM_002609.4 | ENSP00000261799.4 | ||
PDGFRB | ENST00000520579.5 | n.*2566A>G | non_coding_transcript_exon_variant | Exon 23 of 23 | 1 | ENSP00000430026.1 | ||||
PDGFRB | ENST00000520579.5 | n.*2566A>G | 3_prime_UTR_variant | Exon 23 of 23 | 1 | ENSP00000430026.1 |
Frequencies
GnomAD3 genomes AF: 0.365 AC: 55566AN: 152086Hom.: 10616 Cov.: 33
GnomAD3 genomes
AF:
AC:
55566
AN:
152086
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.340 AC: 83370AN: 245412Hom.: 15551 AF XY: 0.347 AC XY: 46145AN XY: 133048
GnomAD3 exomes
AF:
AC:
83370
AN:
245412
Hom.:
AF XY:
AC XY:
46145
AN XY:
133048
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.404 AC: 589752AN: 1459000Hom.: 123688 Cov.: 35 AF XY: 0.403 AC XY: 292118AN XY: 725644
GnomAD4 exome
AF:
AC:
589752
AN:
1459000
Hom.:
Cov.:
35
AF XY:
AC XY:
292118
AN XY:
725644
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.365 AC: 55622AN: 152204Hom.: 10631 Cov.: 33 AF XY: 0.354 AC XY: 26307AN XY: 74412
GnomAD4 genome
AF:
AC:
55622
AN:
152204
Hom.:
Cov.:
33
AF XY:
AC XY:
26307
AN XY:
74412
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
752
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:12
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:5
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing
- -
-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing
- -
-
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing
- -
-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing
- -
-
PreventionGenetics, part of Exact Sciences
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Acroosteolysis-keloid-like lesions-premature aging syndrome Benign:1
Sep 05, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Basal ganglia calcification, idiopathic, 4 Benign:1
Sep 05, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome Benign:1
Sep 05, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Myofibromatosis, infantile, 1 Benign:1
Feb 01, 2025
KCCC/NGS Laboratory, Kuwait Cancer Control Center
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
not provided Benign:1
Jan 10, 2019
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Myeloproliferative disorder, chronic, with eosinophilia Benign:1
Jul 07, 2023
KCCC/NGS Laboratory, Kuwait Cancer Control Center
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Infantile myofibromatosis;C1866182:Acroosteolysis-keloid-like lesions-premature aging syndrome;C3554321:Basal ganglia calcification, idiopathic, 4;C4225270:Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at